or Try an Advanced Search...

    Technical Analysis for PSNL - Personalis, Inc.

    Grade Last Price % Change Price Change
    F 1.40 -2.45% -0.04
    PSNL closed down 2.45 percent on Thursday, May 16, 2024, on 64 percent of normal volume. It ran into resistance at its 50 day moving average. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical PSNL trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    200 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Fell Below 20 DMA Bearish -2.45%
    Older End-of-Day Signals for PSNL ...

       Recent Intraday Alerts

    Alert Time
    Gap Up Closed about 9 hours ago
    1.5x Volume Pace about 9 hours ago
    Down 5% about 9 hours ago
    Down 3% about 9 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PSNL Chart by TradingView
    Basic chart:

    Profile

    Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves approximately 45 biopharmaceutical customers, including a range of pharmaceutical companies. The company was founded in 2011 and is headquartered in Menlo Park, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Biology Telehealth Telemedicine Genomics Medical Genetics Molecular Diagnostics Applied Genetics Cancer Therapies Analysis Services Biopsy Data Analysis Services Cancer Therapy Oncogenomics Treating Cancer

    Is PSNL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Personalis, Inc. (NASDAQ:PSNL) Q1 2024 Earnings Call Transcript
    May 9 Is Personalis (NASDAQ:PSNL) In A Good Position To Deliver On Growth Plans?
    May 9 Personalis First Quarter 2024 Earnings: US$0.26 loss per share (vs US$0.61 loss in 1Q 2023)
    May 9 Q1 2024 Personalis Inc Earnings Call
    May 9 Personalis Inc (PSNL) (Q1 2024) Earnings Call Transcript Highlights: Surpassing Revenue ...
    May 9 Personalis, Inc. (PSNL) Q1 2024 Earnings Call Transcript
    May 8 Personalis GAAP EPS of -$0.26 beats by $0.15, revenue of $19.5M beats by $1.14M
    May 8 Personalis Reports First Quarter 2024 Financial Results
    Apr 24 Personalis to Announce First Quarter 2024 Financial Results
    Apr 17 Cathie Wood's Ark Laps Up $3.3M Worth Of Tesla As Stock Falls For 3rd Straight Session, Sheds Shares Of This Sports Betting Company
    See more PSNL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.59
    52 Week Low 0.8912
    Average Volume 269,225
    200-Day Moving Average 1.46
    50-Day Moving Average 1.46
    20-Day Moving Average 1.46
    10-Day Moving Average 1.54
    Average True Range 0.14
    RSI (14) 45.05
    ADX 28.25
    +DI 23.04
    -DI 17.99
    Chandelier Exit (Long, 3 ATRs) 1.42
    Chandelier Exit (Short, 3 ATRs) 1.61
    Upper Bollinger Bands 1.71
    Lower Bollinger Band 1.20
    Percent B (%b) 0.38
    BandWidth 35.43
    MACD Line 0.03
    MACD Signal Line 0.03
    MACD Histogram -0.0072
    Fundamentals Value
    Market Cap 68.4 Million
    Num Shares 49 Million
    EPS -2.38
    Price-to-Earnings (P/E) Ratio -0.59
    Price-to-Sales 0.83
    Price-to-Book 0.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.62
    Resistance 3 (R3) 1.62 1.55 1.58
    Resistance 2 (R2) 1.55 1.49 1.55 1.57
    Resistance 1 (R1) 1.47 1.45 1.43 1.47 1.56
    Pivot Point 1.40 1.40 1.38 1.40 1.40
    Support 1 (S1) 1.32 1.34 1.28 1.32 1.23
    Support 2 (S2) 1.25 1.30 1.25 1.22
    Support 3 (S3) 1.17 1.25 1.21
    Support 4 (S4) 1.17